{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-300047","form_type":"8-K","ticker":"SRPT","cik":"0000873303","company_name":"Sarepta Therapeutics, Inc.","filed_at":"2021-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.927095+00:00","generated_at":"2026-06-28T20:43:00.995084+00:00","sec_items":["1.01","2.02","2.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sarepta prices $500M common stock offering; preliminary Q3 revenue up 37% to $166.9M","bullets":["Preliminary Q3 2021 net product revenue of ~$166.9M, up from $121.4M in Q3 2020.","Cash, cash equivalents and investments were ~$1.6B as of Sept 30, 2021, down from $1.9B at Dec 31, 2020.","Priced public offering of 6,172,840 shares at $81.00/share for gross proceeds of $500M; net proceeds ~$549.1M.","Underwriters granted 30-day option for additional 925,926 shares, exercised in full; closing expected Oct 18, 2021.","Proceeds to fund clinical trials, commercialization, manufacturing, and potential acquisitions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-300047","json":"https://secwatch.observer/filing/0001193125-21-300047.json","markdown":"https://secwatch.observer/filing/0001193125-21-300047.md","text":"https://secwatch.observer/filing/0001193125-21-300047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/873303/000119312521300047/0001193125-21-300047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/873303/000119312521300047/d228298d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:43:00.995084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}